SureTrader
Home > Boards > US Listed > Cannabis > GW Pharmaceuticals Plc ADS (GWPH)

We'll see where it finishes the day.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
fung_derf Member Profile
Member Level 
Followed By 178
Posts 101,158
Boards Moderated 14
Alias Born 08/30/01
160x600 placeholder
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006 GlobeNewswire Inc. - 2/21/2018 4:01:00 PM
Cannabinoids Lead to Marijuana Biotech Boom NetworkNewsWire - 2/13/2018 8:45:00 AM
Investment Opportunities in Advanced Bioengineered Drug Delivery NetworkNewsWire - 2/7/2018 8:45:00 AM
GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February GlobeNewswire Inc. - 2/6/2018 11:35:58 AM
GW Pharmaceuticals Announces the European Medicines Agency (EMA) Accepts Epidiolex® (cannabidiol) Marketing Authorization Ap... GlobeNewswire Inc. - 2/5/2018 4:00:00 PM
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress GlobeNewswire Inc. - 2/5/2018 4:00:00 PM
GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018 GlobeNewswire Inc. - 1/29/2018 1:00:00 PM
Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development NetworkNewsWire - 1/25/2018 8:45:00 AM
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (Cannabidiol) S... PR Newswire (US) - 1/24/2018 6:30:00 PM
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (cannabidiol) S... GlobeNewswire Inc. - 1/24/2018 6:30:00 PM
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the Treatment of Le... PR Newswire (US) - 12/29/2017 7:00:00 AM
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Le... GlobeNewswire Inc. - 12/29/2017 7:00:00 AM
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndro... GlobeNewswire Inc. - 12/28/2017 7:00:00 AM
GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors GlobeNewswire Inc. - 12/21/2017 7:00:00 AM
Biotech Market Banking on Big Cannabis Returns NetworkNewsWire - 12/19/2017 8:45:00 AM
Dangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic Pain NetworkNewsWire - 12/13/2017 8:45:00 AM
GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S. GlobeNewswire Inc. - 12/13/2017 7:00:00 AM
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exe... GlobeNewswire Inc. - 12/11/2017 5:19:05 PM
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $276 Million GlobeNewswire Inc. - 12/6/2017 9:40:30 PM
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management NetworkNewsWire - 12/6/2017 8:45:00 AM
GW Pharmaceuticals Announces Proposed Public Offering of ADSs GlobeNewswire Inc. - 12/5/2017 4:01:00 PM
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress GlobeNewswire Inc. - 12/4/2017 7:00:00 AM
Investors Could Reap Global Rewards of Research into Medical Cannabis Science NetworkNewsWire - 11/30/2017 8:45:00 AM
GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 4 December, 2017 GlobeNewswire Inc. - 11/27/2017 7:00:00 AM
GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 11/22/2017 7:00:00 AM
fung_derf Member Level  Tuesday, 08/08/17 10:54:52 AM
Re: Eagleize post# 4850
Post # of 4917 
We'll see where it finishes the day.
Next support at $96 BTW, which I see as an even greater opportunity to add if it pulls to there.
Who wants stocks to go straight up? Can't make money that way.


Just my opinion, of course.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist